You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. TITER ON CHIP ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION

    SBC: INDEVR, INC.            Topic: NIAID

    DESCRIPTION provided by applicant It is widely acknowledged that for split vaccines potency determination is often a rate limiting step The FDA approved andquot gold standardandquot potency assay for influenza hemagglutinin HA protein based vaccines is single radial immunodiffusion SRID SRID is a time and labor intensive assay often requiring days to complete and a minimum of hou ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. ElectronicTextile Antennas

    SBC: Applied Radar, Inc.            Topic: SB021014

    Long-duration wide-area surveillance missions increasingly are space-based. MEO orbits offer space-based radar systems more time on station, but require very large array apertures on the order of 100m in diameter. Achieving larger apertures with smaller, lighter launch packages and stable on-orbit pointing is a challenge that E-Textiles promises to meet. Textile processes can be used to achieve a ...

    SBIR Phase II 2008 Department of DefenseArmy
  3. Planar Wideband Phased-Array Element For VHF RADAR

    SBC: FIRST RF CORPORATION            Topic: AF071059

    FIRST RF proposes a compact, broadband, highly integrated VHF SAR antenna array which consists of several key enabling technologies demonstrated during Phase I of this program. FIRST RF took an aggressive design approach in Phase I to prove that the conformal wideband antenna array can be used in conjunction with a robust, wideband beamforming network to steer a SAR beam over the desired angular ...

    SBIR Phase II 2008 Department of DefenseAir Force
  4. Monitoring System For Vector-Based Influenza Vaccine

    SBC: INDEVR, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This Phase II Advanced Technology SBIR [PA-06-134] proposal is in response to NIAID's Notice of High-Priority Influenza Research Areas [NOT-AI-05-013]. In order to provide health officials with the tools required to eff iciently combat a pandemic strain of influenza, it is essential that rapid and cost-effective methods for vaccine production be developed. The ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. OptAgent: A Generalized Framework for the Optimization and Analysis of Agent-based Models

    SBC: OPTIMIZATION TECHNOLOGIES, INC.            Topic: A07070

    The Phase II project will develop prototype software OptAgent™, built on the existing foundation of OptQuest®, a commercial metaheuristic-based optimization engine, to provide a generalized framework for the analysis and optimization of agent-based models by combining optimization algorithms, agent-based simulation, and distributed processing. The software will overcome those weaknesses typica ...

    SBIR Phase II 2008 Department of DefenseArmy
  6. Long-acting Growth Hormone for Treating HIV-Associated Adipose Redistribution Syn

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): HIV-associated adipose redistribution syndrome (HARS), a form of lipodystrophy, is a common problem in HIV patients on highly active antiretroviral therapy and occurs as a side-effect of their anti-viral drug therapies. HARS is characterized by an increase in visceral adipose tissue, dyslipidemia, and insulin insensitivity, all of which are believed to increas ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Interceptor Communications

    SBC: WELKIN SCIENCES, LLC            Topic: MDA06005

    Welkin Sciences proposes to formulate a class of burst-mode communication waveforms tailored for future MDA interceptor communication systems: Advanced Interceptor Data Link (AIDL). The waveform signaling format will support four critical receiver functions: 1) very rapid carrier acquisition and time synchronization; 2) adaptive signal processing to mitigate received signal distortion arising from ...

    SBIR Phase II 2008 Department of DefenseMissile Defense Agency
  8. Expanding small molecule functional metagenomics through shuttle BAC expression i

    SBC: INTACT GENOMICS INC            Topic: NIAID

    DESCRIPTION provided by applicant Hospital acquired microbial infections are the fourth largest killer in America taking lives and adding $ B to hospital costs The emergence of drug resistant microbes has further amplified public health concern Fungi are prolific producers of anti microbial secondary metabolites SM and since the turn of the century have provided of bioactive m ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Multi-Function Radar Seeker (MFS)

    SBC: COLORADO ENGINEERING INC.            Topic: AF131102

    ABSTRACT:Colorado Engineering Inc. (CEI), along with its teammates, proposes to realize the multi-function seeker (MFS) concept in a scalable, heterogeneous, dynamically configurable electronic stack.Leveraging its collective expertise in communication systems design, radar systems design, electromagnetics (EM) analysis and modeling, antenna design, RF design, advanced processing architectures, di ...

    SBIR Phase II 2014 Department of DefenseAir Force
  10. Long Acting Beta Interferon for Treating Multiple Sclerosis- Phase II Continuing

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    Location 2945 Wilderness Place BOULDER, CO 80301 United States 2R44NS040205-04 $1 617 340.00 2 008 Long Acting Beta Interferon for Treating Multiple Sclerosis- Phase II Continuing Department of Health and Human Services National Institutes of Health SBIR ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government